Overlap in the Genetic Architecture of Stroke Risk, Early Neurological Changes, and Cardiovascular Risk Factors.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 16 5 2019
medline: 23 1 2020
entrez: 16 5 2019
Statut: ppublish

Résumé

Background and Purpose- The genetic relationships between stroke risk, stroke severity, and early neurological changes are complex and not completely understood. Genetic studies have identified 32 all stroke risk loci. Polygenic risk scores can be used to compare the genetic architecture of related traits. In this study, we compare the genetic architecture of stroke risk, stroke severity, and early neurological changes with that of 2 stroke risk factors: type 2 diabetes mellitus (T2DM) and hypertension. Methods- We assessed the degree of overlap in the genetic architecture of stroke risk, T2DM, hypertension, and 2 acute stroke phenotypes based on the National Institutes of Health Stroke Scale (NIHSS), which ranges from 0 for no stroke symptoms to 21 to 42 for a severe stroke: baseline (within 6 hours after onset) and change in NIHSS (ΔNIHSS=NIHSS at baseline-NIHSS at 24 hours). This was done by (1) single-nucleotide polymorphism by single-nucleotide polymorphism comparison, (2) weighted polygenic risk scores with sentinel variants, and (3) whole-genome polygenic risk scores using multiple P thresholds. Results- We found evidence of genetic architecture overlap between stroke risk and T2DM ( P=2.53×10

Identifiants

pubmed: 31084338
doi: 10.1161/STROKEAHA.118.023097
pmc: PMC6538457
mid: NIHMS1527011
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1339-1345

Subventions

Organisme : NINDS NIH HHS
ID : K23 NS099487
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS085419
Pays : United States
Organisme : NINDS NIH HHS
ID : U24 NS107230
Pays : United States

Références

Genes Immun. 2009 Jan;10(1):68-76
pubmed: 19092842
Am J Epidemiol. 2005 Aug 1;162(3):267-78
pubmed: 15987729
Stroke. 2011 Oct;42(10):2788-94
pubmed: 21817134
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Am J Hum Genet. 2011 Jan 7;88(1):76-82
pubmed: 21167468
Nat Genet. 2013 Apr;45(4):400-5, 405e1-3
pubmed: 23455638
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
Neurol Int. 2011 Jul 5;3(2):e12
pubmed: 22053259
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Nat Genet. 2018 Apr;50(4):524-537
pubmed: 29531354
Stroke. 2018 Jun;49(6):1325-1331
pubmed: 29686024
Diabetes. 2017 Nov;66(11):2888-2902
pubmed: 28566273
Springerplus. 2016 Jan 20;5:47
pubmed: 26835227
Biol Psychiatry. 2017 Mar 15;81(6):470-477
pubmed: 27765268
Stroke. 2006 Aug;37(8):2181-8
pubmed: 16809576
J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e590-6
pubmed: 23954601
Bioinformatics. 2015 May 1;31(9):1466-8
pubmed: 25550326
Diabetes Metab Syndr. 2018 Jul;12(4):577-584
pubmed: 29571978
Curr Cardiol Rep. 2016 Dec;18(12):124
pubmed: 27796860
Lancet. 1998 Sep 12;352(9131):837-53
pubmed: 9742976
Neurology. 2018 Apr 24;90(17):e1470-e1477
pubmed: 29602916
Stroke. 2011 Jan;42(1):102-6
pubmed: 21106955
Am J Hum Genet. 2017 Dec 7;101(6):939-964
pubmed: 29220677
Stroke. 2017 Jan;48(1):105-110
pubmed: 27924049
PLoS Genet. 2013 Mar;9(3):e1003348
pubmed: 23555274
Neurology. 1999 Jul 13;53(1):126-31
pubmed: 10408548
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Stroke. 2012 Jun;43(6):1537-41
pubmed: 22492517
Alzheimers Dement. 2018 Feb;14(2):205-214
pubmed: 28943286
Nature. 2009 Aug 6;460(7256):748-52
pubmed: 19571811
J Alzheimers Dis. 2018;62(2):745-756
pubmed: 29480181
Genet Epidemiol. 2011 Dec;35(8):809-22
pubmed: 22125221
Nat Genet. 2014 Mar;46(3):234-44
pubmed: 24509480
Transl Psychiatry. 2015 Jun 30;5:e592
pubmed: 26125155
BMJ Open. 2014 Feb 05;4(2):e004387
pubmed: 24500614

Auteurs

Laura Ibanez (L)

From the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.

Laura Heitsch (L)

Division of Emergency Medicine (L.H.), Washington University School of Medicine, St. Louis, MO.
Department of Neurology (L.H., J.-M.L.), Washington University School of Medicine, St. Louis, MO.

Umber Dube (U)

From the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.

Fabiana H G Farias (FHG)

From the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.

John Budde (J)

From the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.

Kristy Bergmann (K)

From the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.

Rich Davenport (R)

From the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.

Joseph Bradley (J)

From the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.

Caty Carrera (C)

Neurovascular Research Laboratory, Vall d'Hebron Institute of Research, Barcelona, Spain (C. Carrera, I.F.-C., J.M.).

Janne Kinnunen (J)

Department of Neurology, Helsinki University Hospital, Finland (J.K., H.S., D.S.).

Hanne Sallinen (H)

Department of Neurology, Helsinki University Hospital, Finland (J.K., H.S., D.S.).

Daniel Strbian (D)

Department of Neurology, Helsinki University Hospital, Finland (J.K., H.S., D.S.).

Agnieszka Slowik (A)

Department of Neurology, Jagiellonian University Medical College, Kraków, Poland (A.S.).

Israel Fernandez-Cadenas (I)

Neurovascular Research Laboratory, Vall d'Hebron Institute of Research, Barcelona, Spain (C. Carrera, I.F.-C., J.M.).

Joan Montaner (J)

Neurovascular Research Laboratory, Vall d'Hebron Institute of Research, Barcelona, Spain (C. Carrera, I.F.-C., J.M.).
Institute of Biomedicine of Seville (IBiS), Hospital Universitario Virgen del Rocío, Consejo Superior de Investigaciones Cientificas (CSIC), University of Seville, Spain (J.M.).
Department of Neurology, Hospital Universitario Virgen Macarena, Seville, Spain (J.M.).

Jin-Moo Lee (JM)

Department of Neurology (L.H., J.-M.L.), Washington University School of Medicine, St. Louis, MO.

Carlos Cruchaga (C)

From the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH